YU42066B - Processfor obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine - Google Patents

Processfor obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine

Info

Publication number
YU42066B
YU42066B YU33/83A YU3383A YU42066B YU 42066 B YU42066 B YU 42066B YU 33/83 A YU33/83 A YU 33/83A YU 3383 A YU3383 A YU 3383A YU 42066 B YU42066 B YU 42066B
Authority
YU
Yugoslavia
Prior art keywords
processfor
naphthylamine
tetrahydro
phenyl
obtaining trans
Prior art date
Application number
YU33/83A
Other languages
English (en)
Other versions
YU3383A (en
Inventor
W M Welch
C A Harbert
B K Kobe
A R Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26782055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU42066(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of YU3383A publication Critical patent/YU3383A/xx
Publication of YU42066B publication Critical patent/YU42066B/xx
Priority to BA970194A priority Critical patent/BA97194B1/bs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/21Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU33/83A 1979-11-01 1983-01-07 Processfor obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine YU42066B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BA970194A BA97194B1 (bs) 1979-11-01 1997-08-13 Postupak za dobivanje trans-4-fenil-1,2,3,4-tetrahidro-1-naftalin amina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9023779A 1979-11-01 1979-11-01
US06/184,447 US4556676A (en) 1979-11-01 1980-09-05 Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine

Publications (2)

Publication Number Publication Date
YU3383A YU3383A (en) 1983-09-30
YU42066B true YU42066B (en) 1988-04-30

Family

ID=26782055

Family Applications (2)

Application Number Title Priority Date Filing Date
YU2774/80A YU41744B (en) 1979-11-01 1980-10-30 Process for obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalene amine
YU33/83A YU42066B (en) 1979-11-01 1983-01-07 Processfor obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU2774/80A YU41744B (en) 1979-11-01 1980-10-30 Process for obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalene amine

Country Status (18)

Country Link
US (1) US4556676A (xx)
EP (1) EP0028901B1 (xx)
KR (1) KR840002021B1 (xx)
AR (2) AR225196A1 (xx)
AT (1) ATE2667T1 (xx)
AU (1) AU517842B2 (xx)
CA (1) CA1130816A (xx)
DE (1) DE3062226D1 (xx)
DK (1) DK149308C (xx)
ES (2) ES8201948A1 (xx)
FI (1) FI68807C (xx)
GR (1) GR70782B (xx)
IE (1) IE50396B1 (xx)
IL (1) IL61376A (xx)
NO (1) NO149102C (xx)
PH (1) PH15468A (xx)
PT (1) PT72005B (xx)
YU (2) YU41744B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4866208A (en) * 1981-12-21 1989-09-12 The Dow Chemical Company Meta-phenylene diamine derivatives
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
US4839104A (en) * 1987-06-11 1989-06-13 Pfizer, Inc. Process for preparing sertraline intermediates
FR2623802B1 (fr) * 1987-11-26 1990-05-04 Lucien Laboratoires Derives d'amino-4 trifluoromethyl-1 tetralines. leur preparation et leur application en therapeutique
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
FR2665443B1 (fr) * 1990-08-03 1992-11-06 Lucien Laboratoires Derives d'amino-4-methyl-1-tetralines, leur preparation et leur application en therapeutique.
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114948D0 (en) * 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
US5196607A (en) * 1992-02-14 1993-03-23 Pfizer Inc. Process for preparing ketone enantiomer
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5466880A (en) * 1992-09-15 1995-11-14 Pfizer Inc. Process for preparing ketone enantiomer
WO1994022495A1 (en) * 1993-03-31 1994-10-13 The Trustees Of The University Of Pennsylvania Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents
DE69406553T2 (de) * 1993-11-30 1998-02-26 Pfizer Verfahren zur herstellung von chiralen tetralonen
US6455736B1 (en) 1994-12-16 2002-09-24 Uop Llc Process for preparation of pharmaceutically desired sertraline and sertraline analogs
US6410794B1 (en) 1994-12-16 2002-06-25 Uop Llc Process for preparation of pharmaceutically desired chiral tetralone from tetralones
HU222341B1 (hu) * 1996-12-18 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier
IN182588B (xx) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IN187170B (xx) 2000-01-04 2002-02-23 Sun Pharmaceutical Ind Ltd
DE10006411C2 (de) * 2000-02-14 2002-03-07 Huf Huelsbeck & Fuerst Gmbh Elektronischer Zündanlaßschalter für Kraftfahrzeuge und Reserveschlüssel zur Betätigung desselben
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US6482440B2 (en) 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
US6723878B2 (en) 2001-06-15 2004-04-20 Orion Corporation Fermion Method for preparing sertraline
US20040087661A1 (en) * 2002-09-16 2004-05-06 Sepracor, Inc. Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
AU2003272460B2 (en) * 2002-09-16 2009-12-17 Sepracor Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
US20060014838A1 (en) * 2004-07-14 2006-01-19 Sudhakar Valluri Process for converting trans-sertraline to cis-sertraline
CA2957667A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
WO2007143267A2 (en) * 2006-05-31 2007-12-13 Sepracor Inc. Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide
WO2007146796A2 (en) * 2006-06-13 2007-12-21 Ramot At Tel-Aviv University Ltd. Antiproliferative compounds, compositions and methods of use
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
MX2016014780A (es) * 2014-05-13 2017-07-25 Sunovion Pharmaceuticals Inc Metodos y composiciones de dasotralina para el tratamiento del adhd.
WO2015175523A1 (en) * 2014-05-13 2015-11-19 Sunovion Pharmaceuticals Inc. Dosage of dasotraline and method for treatment of adhd
WO2016046669A2 (en) * 2014-09-27 2016-03-31 Mohan M Alapati Compositions and methods for the treatment of depression and neurological diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB793853A (en) * 1954-09-15 1958-04-23 Schering Ag Manufacture of new 3-amino-indanes
DE1098511B (de) * 1959-11-21 1961-02-02 Schering Ag Verfahren zur Abtrennung von analgetisch wirksamen d-1-Phenyl-3-dimethylaminoindan
US3704323A (en) * 1969-12-23 1972-11-28 Squibb & Sons Inc Indane derivatives
GB1420472A (en) * 1972-09-27 1976-01-07 Pfizer Aminophenyltetralin compounds
US4029731A (en) * 1974-11-06 1977-06-14 Pfizer Inc. Aminophenyltetralin compounds
US4045488A (en) * 1974-11-06 1977-08-30 Pfizer Inc. Aminophenyltetralin compounds

Also Published As

Publication number Publication date
PT72005B (en) 1981-08-31
ES506893A0 (es) 1982-09-01
ES496441A0 (es) 1982-01-16
PT72005A (en) 1980-11-01
NO149102C (no) 1984-02-15
YU277480A (en) 1983-09-30
DK149308C (da) 1986-12-08
YU41744B (en) 1987-12-31
DK462480A (da) 1981-05-02
NO149102B (no) 1983-11-07
KR840002021B1 (ko) 1984-11-05
AU6389880A (en) 1981-05-07
AU517842B2 (en) 1981-08-27
CA1130816A (en) 1982-08-31
YU3383A (en) 1983-09-30
GR70782B (xx) 1983-03-23
IE50396B1 (en) 1986-04-16
ATE2667T1 (de) 1983-03-15
AR225196A1 (es) 1982-02-26
DK149308B (da) 1986-04-28
PH15468A (en) 1983-01-24
FI803399L (fi) 1981-05-02
IL61376A0 (en) 1980-12-31
NO803259L (no) 1981-05-04
DE3062226D1 (en) 1983-04-07
KR830004201A (ko) 1983-07-06
IE802260L (en) 1981-05-01
AR229106A1 (es) 1983-06-15
ES8201948A1 (es) 1982-01-16
EP0028901A1 (en) 1981-05-20
IL61376A (en) 1983-10-31
ES8207120A1 (es) 1982-09-01
US4556676A (en) 1985-12-03
FI68807C (fi) 1985-11-11
EP0028901B1 (en) 1983-03-02
FI68807B (fi) 1985-07-31

Similar Documents

Publication Publication Date Title
YU42066B (en) Processfor obtaining trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine
GB2064520B (en) A-aryl-1h-1,2,4-triazole-1-ethanols
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
ZA802092B (en) Substituted 9,10-anthracene-bishydrazones
GB2058766B (en) 5'-aminoalkyl-4,4'-dialkylpsoralens
GB2058767B (en) 4'-substituted-4,5',8-trialklpsoralens
ZA773308B (en) Process for the preparation of 10,19-dihydro-vitamin d compounds
ZA804178B (en) Process for the preparation of 2,6-dialkylcyclohexylamines
GB2044770B (en) 24,24 - difluoro- 25 - hydroxycholecalciferol
NZ193666A (en) 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles
PT66891B (en) Process for the preparation of 1,5 disubstituted-2-pyrrolidones
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
GB8315918D0 (en) 16-oxa-3-methyl-bicyclo-(10.3.1)pentadec-1-ene
IL52424A0 (en) 2,6-methano-2h-1-benzoxocins
CS765780A2 (en) Zpusob pripravy 1,2 bis (nikotinamido) propanu
AU2468877A (en) 1,4 -dicyanobytene
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
CS340780A2 (en) Zpusob vyroby pyrazolo (1,5 c) chinazolinovych derivatu
GB1537635A (en) 15,16-dihydroxyprostaglandins
IL75705A (en) 1,2,5-thiadiazole-1-oxides
ZA804183B (en) 1,2,4-thiadiazolyloxyphenylureas
YU40813B (en) Process for obtaining 1-tert-butylamino-3-(2,5 dichlorophenoxio-2-propanoe
JPS6485961A (en) 3,5-cyclovitamine derivative
NZ194583A (en) 5,6-dihydro-11h-pyrimido (4,5-6)(1,5) benzodiazepin-5-ones
CS515881A2 (en) Zpusob pripravy oktahydropyrazolo(3,4 g) chinolinu